MedTrace Logo

Health Benefits of Expressive Writing: Study One

NCT03546673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2019-09-04

No results posted yet for this study

Summary

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Conditions

Interventions

BEHAVIORAL

Self-Regulation Condition

BEHAVIORAL

Emotional Disclosure Condition

Sponsors & Collaborators

  • Herald Cancer Association

    collaborator OTHER

  • American Cancer Society, Inc.

    collaborator OTHER

  • University of Houston

    lead OTHER

Principal Investigators

  • Qian Lu, Ph.D., MD · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03546673 on ClinicalTrials.gov